Presentation JIM 2019

GP IIb/IIIa inhibitors are still the best option

Presenter: Alberto Menozzi

February 15, 2019

REGISTER for free or LOG IN to view this content

GP IIb/IIIa inhibitors are still the best option

Clinical Cardiology

Clinical Pharma

Coronary

CAD Pharma

Presentation

JIM 2019

PCI

GP IIb/IIIa inhibitors

Up Next

Presentation JIM 2019

Cangrelor is ready for the prime time

Presenter: Giuseppe Musumeci

February 15, 2019

More slides +

Presentation JIM 2019

Magmaris, a Resorbable Magnesium Scaffold here to stay

Presenter: Johan Bennett

February 15, 2019

Presentation JIM 2019

Reproducible and Controlled Trans-septal Puncture System

Presenter: Azeem Latib

February 15, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.